Welcome to our dedicated page for RTTR news (Ticker: RTTR), a resource for investors and traders seeking the latest updates and insights on RTTR stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RTTR's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RTTR's position in the market.
Ritter Pharmaceuticals (Nasdaq: RTTR) announced that it expects to finalize its merger with Qualigen, Inc. after market hours on May 22, 2020. Stockholders approved a reverse stock split of 1-for-25, effective prior to the merger. Following the merger, Ritter will be renamed Qualigen Therapeutics, Inc. and will begin trading under the ticker QLGN on May 26, 2020. Holders of Ritter stock before the split will receive nontransferable contingent value rights, allowing potential cash payments related to the monetization of Ritter's intellectual property concerning gastrointestinal treatments.
Ritter Pharmaceuticals (Nasdaq: RTTR) has adjourned its special stockholders' meeting, originally set for May 14, 2020, to May 18, 2020, to allow more time for proxy solicitation regarding its proposed merger with Qualigen, Inc.. The meeting is aimed at approving various merger-related proposals previously detailed in a joint proxy statement. The record date for stockholders eligible to vote remains March 26, 2020, and valid proxies submitted will remain effective for the reconvened meeting. Stockholders can attend the virtual meeting on May 18 by entering their control numbers.
